BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21308311)

  • 1. Dysplastic nevus (atypical nevus).
    Rezze GG; Leon A; Duprat J
    An Bras Dermatol; 2010; 85(6):863-71. PubMed ID: 21308311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
    Drozdowski R; Spaccarelli N; Peters MS; Grant-Kels JM
    J Am Acad Dermatol; 2023 Jan; 88(1):1-10. PubMed ID: 36038073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilemma of the dysplastic nevus.
    Salopek TG
    Dermatol Clin; 2002 Oct; 20(4):617-28, viii. PubMed ID: 12380049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
    Elder DE; Clark WH; Elenitsas R; Guerry D; Halpern AC
    Semin Diagn Pathol; 1993 Feb; 10(1):18-35. PubMed ID: 8506414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dysplastic nevus: recognition and management.
    Barnhill RL; Hurwitz S; Duray PH; Arons MS
    Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplastic nevus: Fact and fiction.
    Rosendahl CO; Grant-Kels JM; Que SK
    J Am Acad Dermatol; 2015 Sep; 73(3):507-12. PubMed ID: 26037217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data.
    Bauer J; Garbe C
    Pigment Cell Res; 2003 Jun; 16(3):297-306. PubMed ID: 12753404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma.
    Clark WH; Tucker MA
    Hum Pathol; 1998 Jan; 29(1):8-14. PubMed ID: 9445128
    [No Abstract]   [Full Text] [Related]  

  • 16. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications.
    Pampena R; Kyrgidis A; Lallas A; Moscarella E; Argenziano G; Longo C
    J Am Acad Dermatol; 2017 Nov; 77(5):938-945.e4. PubMed ID: 28864306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histopathology of dysplastic nevi. Continued controversy.
    Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
    Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The precursors of malignant melanoma.
    Crowson AN; Magro CM; Sanchez-Carpintero I; Mihm MC
    Recent Results Cancer Res; 2002; 160():75-84. PubMed ID: 12079242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic melanocytic nevi. Normal variants or melanoma precursors?
    Murphy GF; Halpern A
    Arch Dermatol; 1990 Apr; 126(4):519-22. PubMed ID: 2321997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.